Analysis of HLA-G gene expression in B-lymphocytes from chronic lymphocytic leukemia patients

Iranian Biomedical Journal

Volumn 11, Issue 2, 2007, Pages 125-129

  Rezvany, Mohammad Reza ^a,b   Kazemi, Azam ^c   Hajifathali, Abbas ^d   Kaviani, Saeed ^c   Mellstedt, Håkan ^b  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

B cell chronic lymphocytic leukemia (B CLL); Human leukocyte antigen G (HLA G); Reverse transcription PCR (RT) PCR

Indexed keywords

HLA G ANTIGEN; MESSENGER RNA;

AGED; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; B-LYMPHOCYTES; DNA PRIMERS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34249075478     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chiorazzi, N., Rai, K.R. and Ferrarini, M. (2005) Chronic lymphocytic leukemia. N. Engl. J. Med. 8: 804-815.
2. Kovats, S., Main, E.K., Librach, C., Stubblebine, M., Fisher, S.J. and DeMars, R. (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 4952: 220-223.
3. LeMaoult, J., Rouas-Freiss, N. and Carosella, E.D. (2005) Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. Autoimmun. Rev. 8: 503-509.
4. Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J. and Carosella, E.D. (2001) HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J. Immunol. 8: 5018-5026.
5. LeMaoult, J., Zafaranloo, K., Le Danff, C. and Carosella, E.D. (2005) HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 6: 662-664.
6. Carosella, E.D. and Dausset, J. (2003) Progress of HLA-G in cancer. Semin. Cancer Biol. 5: 315-316.
7. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss EH, Melms A, and Weller M. (2002) A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J. Immunol. 9: 4772-4780.
8. Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F.A., Avril, M.F., Dausset, J., Guillet, J.G. and Carosella, E.D. (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc. Natl. Acad. Sci. USA 8: 4510-4515.
9. Rouas-Freiss, N., Moreau, P., Ferrone, S. and Carosella, E.D. (2005) HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res. 22: 10139-10144.
10. Ibrahim, E.C., Guerra, N., Lacombe, M.J., Angevin, E., Chouaib, S., Carosella, E.D., Caignard, A. and Paul, P. (2001) Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res. 18: 6838-6845.
11. Lefebvre, S., Antoine, M., Uzan, S., McMaster, M., Dausset, J., Carosella, E.D. and Paul, P. (2002) Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J. Pathol. 3: 266-274.
12. Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G. and Dummer, R. (2002) HLA-G protein upregulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2: 609-617.
13. Amiot, L., Le Friec, G., Sebti, Y., Drenou, B., Pangault, C., Guilloux, V., Leleu, X., Bernard, M., Facon, T. and Fauchet, R. (2003) HLA-G and lymphoproliferative disorders. Semin Cancer Biol. 5: 379-385.
14. Singer, G., Rebmann, V., Chen, Y.C., Liu, H.T., Ali, S.Z., Reinsberg, J., McMaster, M.T., Pfeiffer, K., Chan, D.W., Wardelmann, E., Grosse-Wilde, H., Cheng, C.C., Kurman, R.J. and Shih Ie, M. (2003) HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res. 12: 4460-4464.
15. Hansel, D.E., Rahman, A., Wilentz, R.E., Shih Ie, M., McMaster, M.T., Yeo, C.J. and Maitra, A. (2005) HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int. J. Gastrointest. Cancer. 1: 15-23.
16. Boyum A. (1977) Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology 2: 71-76.
17. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1: 156-159.
18. Rezvany, M.R., Jeddi-Tehrani, M., Osterborg, A., Kimby, E., Wigzell, H. and Mellstedt, H. (1999) Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 3: 1063-1069.
19. Cabestre, F.A., Lefebvre, S., Moreau, P., Rouas-Friess, N., Dausset, J., Carosella, E.D. and Paul, P. (1999) HLA-G expression: immune privilege for tumor cells? Semin. Cancer Biol. 1: 27-36.
20. Polakova, K., Krcova, M., Kuba, D. and Russ, G. (2003) Analysis of HLA-G expression in malignant hematopoietic cells from leukemia patients. Leuk. Res. 7: 643-648.
21. Amiot, L., Onno, M., Drenou, B., Monvoisin, C. and Fauchet, R. (1998) HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol. 8: 524-528.
22. Mizuno, S., Emi, N., Kasai, M., Ishitani, A. and Saito, H. (2000) Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukemia. Br. J. Haematol. 1: 280-282.
23. Nuckel, H., Rebmann, V., Durig, J., Duhrsen, U. and Grosse-Wilde, H. (2005) HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 4: 1694-1698.